COBENFY for the Treatment of Schizophrenia, US
Schizophrenia is a chronic and debilitating mental disorder that impacts the way an individual thinks, feels, and acts.
Bristol-Meyers Squibb
Speciality Biopharmaceutical Company
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP
About Us
Bristol-Myers Squibb Co (BMS) is a speciality biopharmaceutical company that is engaged in the discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, US.
Projects
Contact Details
Website
Address
430 E. 29th Street, 14 Floor, New York, 10016,
United States of America
United States of America
Phone
Regional Offices
Address
Bristol-Meyers Squibb
430 E. 29th Street, 14 Floor, New York, 10016
United States of America